First New Drug for Liver Cancer in a Decade: Regorafenib - Medscape

Medscape

First New Drug for Liver Cancer in a Decade: Regorafenib Medscape The US Food and Drug Administration (FDA) has expanded the indication for regorafenib (Stivarga, Bayer) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated with the drug sorafenib (Nexavar, Bayer). FDA Approves Regorafenib for Liver CancerCancer Network FDA expands approved use of Stivarga to treat liver cancerFDA.gov Bayer's Stivarga Shows Slim Progress Against Liver CancerForbes Newswise (press release) -HealthDay -Reuters -Healio all 16 news articles »

from Health - Google News http://ift.tt/2oS4RV5